Does Regence Cover Ozempic? Diabetes, Wegovy, and Appeals

Regence does cover Ozempic, but only when it is prescribed to treat type 2 diabetes and almost always after prior authorization. If the prescription is for weight loss alone, Regence treats it as not medically necessary and excludes it from coverage under most contracts.1Regence MyPrime. Preferred GLP-1 Agonist-Containing Medications for Diabetes, Policy No. dru750

Coverage for Type 2 Diabetes

Under Regence medication policy dru750, effective April 15, 2026, Ozempic is one of four preferred GLP-1 agonists for type 2 diabetes, alongside Mounjaro, Trulicity, and Rybelsus. Regence describes these four as offering the “best value for members.” Coverage runs through the pharmacy benefit as a self-administered medication, with quantities capped at one pen per 28 days or 30 tablets per 30 days.1Regence MyPrime. Preferred GLP-1 Agonist-Containing Medications for Diabetes, Policy No. dru750

What Prior Authorization Requires

To approve a new prescription, Regence needs one of two things on file:

  • A type 2 diabetes diagnosis documented with an ICD-10 code in the E11 family, or
  • A prescription history showing at least one adjudicated and paid claim within the past two years for a qualifying diabetes medication such as metformin, insulin, a sulfonylurea, an SGLT2 inhibitor, or a DPP-4 inhibitor.

The policy does not set a specific A1C threshold and does not require that a patient have tried and failed any particular drug first. It simply requires evidence of an established diabetes treatment history. Once approved, authorization is reviewed each year, and the prescriber must submit chart notes confirming ongoing medical necessity and clinical benefit.1Regence MyPrime. Preferred GLP-1 Agonist-Containing Medications for Diabetes, Policy No. dru750

Uses Regence Will Not Cover

Beyond weight loss, Regence considers Ozempic investigational and non-coverable for type 1 diabetes, diabetic ketoacidosis, islet-cell transplantation, and concurrent use with another GLP-1 agonist or with pramlintide (Symlin).1Regence MyPrime. Preferred GLP-1 Agonist-Containing Medications for Diabetes, Policy No. dru750

Why Weight-Loss Prescriptions Are Denied

The diabetes policy is explicit: Ozempic is “not medically necessary and excluded from coverage” when used for weight loss in the absence of other coverable medical conditions, and the exclusion applies “regardless of medical necessity” under most benefit contracts.1Regence MyPrime. Preferred GLP-1 Agonist-Containing Medications for Diabetes, Policy No. dru750

Whether any GLP-1 is available for weight loss depends on your specific plan contract. Some Regence plans exclude obesity and overweight treatments entirely, and in those cases no clinical documentation will unlock coverage. Check your benefit booklet or call Regence to confirm whether your contract includes an obesity benefit before pursuing a weight-loss prescription.2Regence MyPrime. GLP-1 Agonist-Containing Medications for Non-Diabetic Indications, Policy No. dru787

Wegovy Is the Weight-Loss Pathway

If your plan does include obesity coverage, the relevant drug is Wegovy, not Ozempic. Regence governs semaglutide for weight loss under a separate policy (dru787) that also covers Zepbound and Saxenda. Approval pathways include adults with a BMI of 30 or higher, adults with a BMI of 27 or higher who have a weight-related comorbidity such as hypertension or cardiovascular disease, and some patients with established cardiovascular disease or confirmed MASH/NASH liver disease. Every pathway requires prior authorization, annual reauthorization showing clinical benefit, and the member’s attestation that the drug will be used alongside diet, exercise, or nutritional counseling.2Regence MyPrime. GLP-1 Agonist-Containing Medications for Non-Diabetic Indications, Policy No. dru787

The New Oral Ozempic

In March 2026, Regence updated dru750 to add an oral tablet formulation of Ozempic, which became available nationwide on May 4, 2026 in 1.5 mg, 4 mg, and 9 mg strengths.3EMPR. Ozempic Semaglutide Tablets Available Nationwide Starting May 4 The tablets fall under the same diabetes policy as the injectable pen, with coverage capped at 30 tablets per 30 days. Regence has said that Rybelsus will stay on the formulary until existing supply runs out, and the Ozempic tablet is expected to replace it.1Regence MyPrime. Preferred GLP-1 Agonist-Containing Medications for Diabetes, Policy No. dru750

What You Will Pay

The list price for Ozempic is roughly $1,028 per pen or per 30-tablet bottle, which puts retail cost at $1,000 or more per month.4Novo Nordisk. Ozempic Explaining List Price If your Regence plan covers it, your out-of-pocket cost depends on your plan’s tier and cost-sharing rules.

Members with commercial Regence coverage whose plan covers Ozempic can use Novo Nordisk’s savings card, which brings the copay as low as $25 per fill, up to $100 in savings per monthly fill, for as long as 48 months. Patients on Medicare or Medicaid are not eligible for that card.5Novo Nordisk. Save on Ozempic

For patients without any coverage, NovoCare Pharmacy offers self-pay prices between $149 and $499 per month depending on formulation and dose. Novo Nordisk’s Patient Assistance Program may supply the medication free of charge to qualifying uninsured patients with household income at or below 200% of the federal poverty level. Patients with private insurance, including Regence, are not eligible for the PAP.6Novo Nordisk. Patient Assistance Program A generic version of semaglutide is not expected in the United States until at least 2031.7NBC News. Generic Ozempic in the United States

Appealing a Denial

A denial is not the end of the road. Start by requesting the denial in writing so you know whether it was based on missing clinical criteria, missing documentation, or a plan exclusion. Then compare that reason against your actual plan document. This matters especially for self-insured employer plans, where the employer’s plan terms, not Regence’s general policy, control coverage.8Obesity Action Coalition. Appealing a Denial

Build the appeal around clinical evidence: chart notes, A1C and fasting glucose results, documentation of prior diabetes medications, and comorbidities. A detailed letter of medical necessity from your prescriber carries real weight. Check that the submitted ICD-10 codes are correct, since coding errors are a common and easily fixable cause of denials. Most insurers accept appeals by mail or fax, and the filing window is typically six months, though self-insured employer plans may shorten that to 60 days. If the internal appeal fails, you generally have up to 365 days to request an independent external review.8Obesity Action Coalition. Appealing a Denial Prescribers can also submit a formulary exception request if the denial relates to tiering or step therapy.

Washington UMP and Medicare Advantage Members

Washington state and school employees enrolled in the Uniform Medical Plan have Regence as administrator, but their pharmacy benefit runs through ArrayRx under a separate formulary. UMP uses tiered coinsurance that ranges from $0 for preventive medications up to 30% for Tier 2 drugs.9Washington State Health Care Authority. UMP Preferred Drug List Verify current coverage and any prior authorization requirements at ump.regence.com or by calling ArrayRx at 1-888-361-1611.

Regence Medicare Advantage plans with Part D use a five-tier formulary, and Ozempic’s tier and cost-sharing vary by plan.10Regence. BlueAdvantage HMO Summary of Benefits Check your plan’s formulary at regence.com/medicare or call 1-855-522-8896. Medicare members cannot use Novo Nordisk’s commercial savings card, but the Medicare Prescription Payment Plan can spread the annual cost across monthly installments.